13 January 2022 Scorpion Therapeutics Enters Agreement With Astrazeneca To Discover, Develop And Commercialize Novel Cancer Treatments Against ‘Undruggable’ Targets read more
17 November 2021 Protego Biopharma Raises $51 Million Series A Financing to Advance the Treatment of Protein Misfolding Diseases read more
26 October 2021 Quanta Therapeutics Announces Oversubscribed $60 Million Series C Financing to Advance Novel RAS-targeting Programs read more
21 October 2021 ReCode Therapeutics Raises Oversubscribed Series B Financing Round of $80 Million read more
